Form 4 for IMDX Insight Molecular Diagnostics Inc.
Accepted 2022-12-28 00:00:00 ET · period of report 2022-12-23 · accession 0001493152-22-036655 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-28 | 2022-12-23 | IMDX | Arno Andrew | Dir | P - Purchase | $0.35 | +250.0K | 532.0K | +89% | +$87.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, no par value | 2022-12-23 | P | A | 250,000 | $0.35 | 532,049 | D | — | — | (F1) The price of $0.3515 per share represents a weighted average of prices ranging from $0.29 to $0.4284 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |